✨ Medicines Distribution Consents




NEW ZEALAND GAZETTE

No. 90

Health

Medicines Act 1981

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product:
Capril

Active Ingredient:
Captopril 12.5mg

Dosage Form:
Tablet

New Zealand Sponsor:
Pacific Pharmaceuticals Limited

Manufacturer:
Genpharm Inc., Etobicoke, Ontario, Canada

Product:
Capril

Active Ingredient:
Captopril 25mg

Dosage Form:
Tablet

New Zealand Sponsor:
Pacific Pharmaceuticals Limited

Manufacturer:
Genpharm Inc., Etobicoke, Ontario, Canada

Product:
Capril

Active Ingredient:
Captopril 50mg

Dosage Form:
Tablet

New Zealand Sponsor:
Pacific Pharmaceuticals Limited

Manufacturer:
Genpharm Inc., Etobicoke, Ontario, Canada

Product:
Wartec

Active Ingredient:
Podophyllotoxin 0.15%w/w

Dosage Form:
Topical cream

New Zealand Sponsor:
New Zealand Medical & Scientific Limited

Manufacturer:
Stiefel Laboratories (Ireland) Limited, Sligo, Ireland

Dated this 24th day of July 2002.

G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).

go5042

Provisional Consent to the Distribution of a New Medicine

Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:

Schedule

Product:
Fasturtec

Active Ingredient:
Rasburicase 1.5mg

Dosage Form:
Powder for infusion

New Zealand Sponsor:
Sanofi-Synthelabo (NZ) Limited

Manufacturer:
Sanofi Winthrop Industrie, Notre Dame de Bondeville, France

Note: This consent is valid for two years from the date of publication of this notice.

Dated this 24th day of July 2002.

G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).

go5044

Consent to the Distribution of a New Related Product

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new related product set out in the schedule hereto:

Schedule

Product:
Reach Harry Potter

Active Ingredient:
Sodium fluoride 0.2%w/w

Dosage Form:
Toothpaste

New Zealand Sponsor:
Johnson & Johnson Pacific New Zealand

Manufacturer:
Sheffield Laboratories, New London, Connecticut, United States of America



Next Page →



Online Sources for this page:

VUW Te Waharoa PDF NZ Gazette 2002, No 90


Gazette.govt.nz PDF NZ Gazette 2002, No 90





✨ LLM interpretation of page content

πŸ₯ Consent to Distribution of New Medicines

πŸ₯ Health & Social Welfare
24 July 2002
Medicines, Distribution, Consent, Capril, Wartec, Captopril, Podophyllotoxin
  • G. R. Boyd, Chief Advisor, Safety and Regulation

πŸ₯ Provisional Consent to Distribution of New Medicine

πŸ₯ Health & Social Welfare
24 July 2002
Medicines, Provisional Consent, Distribution, Fasturtec, Rasburicase
  • G. R. Boyd, Chief Advisor, Safety and Regulation

πŸ₯ Consent to Distribution of New Related Product

πŸ₯ Health & Social Welfare
24 July 2002
Medicines, Related Product, Distribution, Consent, Reach Harry Potter, Sodium fluoride
  • G. R. Boyd, Chief Advisor, Safety and Regulation